Risk of COVID-19 in the IBD Evusheld cohort compared to IBD control cohort and non-IBD control before and after propensity score matching.
Cohort . | N (%) . | Before propensity score matching . | N (%) . | After propensity score matching . |
---|---|---|---|---|
aOR (95% CI) . | aOR (95% CI) . | |||
IBD Evusheld | 55 (13.4%) | 2.57 (1.93-3.42) | 51 (13%) | 1.35 (0.87–2.10) |
IBD Control | 3793 (5.7%) | 39 (10%) | ||
IBD Evusheld | 55 (13.4%) | 1.36 (1.01-1.82) | 52 (12.9%) | 1.02 (0.67–1.54) |
Non-IBD control | 1021 (10.2%) | 51 (12.7%) |
Cohort . | N (%) . | Before propensity score matching . | N (%) . | After propensity score matching . |
---|---|---|---|---|
aOR (95% CI) . | aOR (95% CI) . | |||
IBD Evusheld | 55 (13.4%) | 2.57 (1.93-3.42) | 51 (13%) | 1.35 (0.87–2.10) |
IBD Control | 3793 (5.7%) | 39 (10%) | ||
IBD Evusheld | 55 (13.4%) | 1.36 (1.01-1.82) | 52 (12.9%) | 1.02 (0.67–1.54) |
Non-IBD control | 1021 (10.2%) | 51 (12.7%) |
Abbreviations: aOR, adjusted odds ratio; CI, confidence interval; IBD, inflammatory bowel disease.
Risk of COVID-19 in the IBD Evusheld cohort compared to IBD control cohort and non-IBD control before and after propensity score matching.
Cohort . | N (%) . | Before propensity score matching . | N (%) . | After propensity score matching . |
---|---|---|---|---|
aOR (95% CI) . | aOR (95% CI) . | |||
IBD Evusheld | 55 (13.4%) | 2.57 (1.93-3.42) | 51 (13%) | 1.35 (0.87–2.10) |
IBD Control | 3793 (5.7%) | 39 (10%) | ||
IBD Evusheld | 55 (13.4%) | 1.36 (1.01-1.82) | 52 (12.9%) | 1.02 (0.67–1.54) |
Non-IBD control | 1021 (10.2%) | 51 (12.7%) |
Cohort . | N (%) . | Before propensity score matching . | N (%) . | After propensity score matching . |
---|---|---|---|---|
aOR (95% CI) . | aOR (95% CI) . | |||
IBD Evusheld | 55 (13.4%) | 2.57 (1.93-3.42) | 51 (13%) | 1.35 (0.87–2.10) |
IBD Control | 3793 (5.7%) | 39 (10%) | ||
IBD Evusheld | 55 (13.4%) | 1.36 (1.01-1.82) | 52 (12.9%) | 1.02 (0.67–1.54) |
Non-IBD control | 1021 (10.2%) | 51 (12.7%) |
Abbreviations: aOR, adjusted odds ratio; CI, confidence interval; IBD, inflammatory bowel disease.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.